Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2015 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
KURA on Nasdaq
Shares outstanding
87,054,674
Price per share
$8.63
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
85,163,526
Total reported value
$884,706,924
% of total 13F portfolios
0%
Share change
+1,439,277
Value change
+$19,983,041
Number of holders
207
Price from insider filings
$8.63
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOTECHNOLOGY VALUE FUND L P 10% +31% $76,791,609 +$24,465,506 8,677,018 +47% BVF PARTNERS L P/IL 30 Sep 2025
SUVRETTA CAPITAL MANAGEMENT, LLC 9.4% +39% $49,222,110 +$15,381,900 7,561,000 +45% SUVRETTA CAPITAL MANAGEMENT, LLC 31 Mar 2025
BlackRock, Inc. 7.8% -24% $41,202,116 -$10,448,902 6,329,050 -20% BlackRock, Inc. 31 Mar 2025
ARMISTICE CAPITAL, LLC 5.7% +6% $42,597,680 +$2,278,320 4,936,000 +5.7% Armistice Capital, LLC 31 Dec 2025
STATE STREET CORP 5.7% $45,218,095 4,931,090 STATE STREET CORPORATION 31 Dec 2025
EcoR1 Capital, LLC 4.8% $23,520,000 4,200,000 EcoR1 Capital, LLC 30 Jun 2025
RA CAPITAL MANAGEMENT, L.P. 4.9% $26,070,011 4,004,610 RA Capital Management, L.P. 31 Mar 2025

As of 31 Dec 2025, 207 institutional investors reported holding 85,163,526 shares of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA). This represents 98% of the company’s total 87,054,674 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) together control 80% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 10% 9,010,793 -5.3% 0% $93,622,139
BVF INC/IL 9.9% 8,617,162 0% 3% $89,532,313
SUVRETTA CAPITAL MANAGEMENT, LLC 9.9% 8,575,422 +5.7% 2.2% $89,098,635
VANGUARD GROUP INC 6.3% 5,507,627 +0.72% 0% $57,224,245
ARMISTICE CAPITAL, LLC 5.7% 4,936,000 +5.7% 1.3% $51,285,040
STATE STREET CORP 5.7% 4,931,090 +47% 0% $51,234,025
AQR CAPITAL MANAGEMENT LLC 3.5% 3,062,212 +37% 0.02% $31,816,384
Prosight Management, LP 2.9% 2,529,600 -8.3% 5.4% $26,282,544
GEODE CAPITAL MANAGEMENT, LLC 2.3% 2,028,618 -0.94% 0% $21,081,811
JACOBS LEVY EQUITY MANAGEMENT, INC 2.3% 2,022,333 -9.1% 0.08% $21,012,040
GOLDMAN SACHS GROUP INC 2.1% 1,837,264 -30% 0% $19,089,173
RENAISSANCE TECHNOLOGIES LLC 2.1% 1,830,566 +112% 0.03% $19,019,581
MILLENNIUM MANAGEMENT LLC 1.8% 1,584,399 -24% 0.01% $16,461,906
ALETHEA CAPITAL MANAGEMENT, LLC 1.6% 1,422,682 +2.4% 7.2% $14,781,666
MORGAN STANLEY 1.6% 1,389,828 -23% 0% $14,440,320
Qube Research & Technologies Ltd 1.5% 1,333,523 -22% 0.02% $13,855,304
Assenagon Asset Management S.A. 1.3% 1,145,016 -9.5% 0.02% $11,896,716
AMERICAN CENTURY COMPANIES INC 1.3% 1,117,042 +67% 0.01% $11,606,066
DIMENSIONAL FUND ADVISORS LP 1.2% 1,077,818 -5.4% 0% $11,197,203
UBS Group AG 1.2% 1,060,025 +118% 0% $11,013,660
NAN FUNG TRINITY (HK) LTD 1.1% 964,880 +318% 0.79% $10,025,103
ACADIAN ASSET MANAGEMENT LLC 1% 886,579 -16% 0.02% $9,210,000
Rhenman & Partners Asset Management AB 1% 872,000 +78% 0.85% $9,060,080
BANK OF AMERICA CORP /DE/ 0.97% 842,128 +47% 0% $8,749,710
NORTHERN TRUST CORP 0.83% 723,217 -4% 0% $7,514,225

Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 85,163,526 $884,706,924 +$19,983,041 $10.39 207
2025 Q3 83,953,188 $743,091,012 +$26,560,344 $8.85 198
2025 Q2 82,161,271 $474,076,451 +$3,886,077 $5.77 180
2025 Q1 80,481,583 $531,240,145 -$1,742,391 $6.60 183
2024 Q4 78,800,102 $686,302,860 -$217,671,932 $8.71 184
2024 Q3 82,360,607 $1,606,956,703 +$4,044,498 $19.54 178
2024 Q2 80,489,635 $1,657,260,003 -$4,649,743 $20.59 173
2024 Q1 80,704,151 $1,721,386,349 +$47,334,824 $21.33 162
2023 Q4 78,750,714 $1,132,429,796 +$48,405,539 $14.38 138
2023 Q3 75,320,060 $686,894,075 -$2,210,555 $9.12 131
2023 Q2 75,143,461 $795,074,726 +$20,118,060 $10.58 147
2023 Q1 72,452,228 $885,285,317 +$27,367,401 $12.23 140
2022 Q4 70,164,281 $870,596,716 -$25,367,145 $12.41 139
2022 Q3 71,584,721 $977,803,865 -$10,119,008 $13.66 144
2022 Q2 68,658,415 $1,258,498,156 +$54,233,601 $18.33 142
2022 Q1 65,777,551 $1,057,605,942 +$39,092,796 $16.08 142
2021 Q4 64,108,565 $897,784,334 -$107,625,141 $14.00 143
2021 Q3 66,738,474 $1,250,027,023 -$22,664,956 $18.73 149
2021 Q2 67,619,494 $1,409,907,095 -$33,759,405 $20.85 163
2021 Q1 68,584,982 $1,942,401,972 +$106,818,236 $28.27 162
2020 Q4 65,052,975 $2,124,984,562 +$353,968,960 $32.66 192
2020 Q3 53,818,393 $1,648,931,451 +$50,643,099 $30.64 160
2020 Q2 52,442,231 $855,540,393 +$213,208,168 $16.30 129
2020 Q1 39,802,987 $394,470,751 +$5,045,270 $9.95 113
2019 Q4 38,979,999 $536,059,777 -$17,580,300 $13.75 125
2019 Q3 40,174,979 $609,372,943 +$18,475,235 $15.17 114
2019 Q2 38,684,419 $761,718,678 +$133,021,751 $19.69 121
2019 Q1 32,044,753 $531,121,734 -$3,584,064 $16.59 100
2018 Q4 32,415,330 $454,789,379 -$2,761,213 $14.04 95
2018 Q3 30,235,029 $529,138,565 +$7,587,244 $17.50 112
2018 Q2 29,714,074 $540,689,653 +$112,569,821 $18.20 108
2018 Q1 23,570,284 $441,929,475 +$77,404,250 $18.75 98
2017 Q4 19,535,236 $298,877,651 +$581,471 $15.30 73
2017 Q3 19,416,540 $290,234,810 +$128,771,717 $14.95 64
2017 Q2 10,813,395 $100,551,904 +$4,771,007 $9.30 42
2017 Q1 10,310,503 $90,718,000 +$4,182,413 $8.80 34
2016 Q4 9,877,148 $58,241,000 +$736,496 $5.90 29
2016 Q3 9,748,853 $60,931,000 +$2,850,289 $6.25 25
2016 Q2 9,319,042 $25,248,000 -$3,677,975 $2.71 25
2016 Q1 10,225,954 $41,413,000 -$249,669 $4.05 20
2015 Q4 10,246,869 $86,073,000 +$80,324,000 $8.40 14